| pubmed-article:10063812 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10063812 | lifeskim:mentions | umls-concept:C0010286 | lld:lifeskim |
| pubmed-article:10063812 | lifeskim:mentions | umls-concept:C0031634 | lld:lifeskim |
| pubmed-article:10063812 | lifeskim:mentions | umls-concept:C1708715 | lld:lifeskim |
| pubmed-article:10063812 | lifeskim:mentions | umls-concept:C2346689 | lld:lifeskim |
| pubmed-article:10063812 | lifeskim:mentions | umls-concept:C0392760 | lld:lifeskim |
| pubmed-article:10063812 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:10063812 | pubmed:dateCreated | 1999-5-27 | lld:pubmed |
| pubmed-article:10063812 | pubmed:abstractText | Oral creatine supplementation has been shown to improve power output during high intensity intermittent muscle contractions. Facilitated muscle phosphocreatine (PCr) resynthesis, by virtue of elevated intracellular PCr concentration, might contribute to this ergogenic action. Therefore, the effect of creatine loading (C: 25 g X d(-1) for 5 d) on muscle PCr breakdown and resynthesis and muscle performance during high intensity intermittent muscle contractions was investigated. | lld:pubmed |
| pubmed-article:10063812 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10063812 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10063812 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10063812 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10063812 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10063812 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10063812 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10063812 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:10063812 | pubmed:issn | 0195-9131 | lld:pubmed |
| pubmed-article:10063812 | pubmed:author | pubmed-author:VandenbergheK... | lld:pubmed |
| pubmed-article:10063812 | pubmed:author | pubmed-author:VanstapelFF | lld:pubmed |
| pubmed-article:10063812 | pubmed:author | pubmed-author:Van HeckePP | lld:pubmed |
| pubmed-article:10063812 | pubmed:author | pubmed-author:HespelPP | lld:pubmed |
| pubmed-article:10063812 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:10063812 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10063812 | pubmed:volume | 31 | lld:pubmed |
| pubmed-article:10063812 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10063812 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10063812 | pubmed:pagination | 236-42 | lld:pubmed |
| pubmed-article:10063812 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:meshHeading | pubmed-meshheading:10063812... | lld:pubmed |
| pubmed-article:10063812 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10063812 | pubmed:articleTitle | Phosphocreatine resynthesis is not affected by creatine loading. | lld:pubmed |
| pubmed-article:10063812 | pubmed:affiliation | Faculty of Physical Education and Physiotherapy, Department of Kinesiology and Faculty of Medicine, Katholieke Universiteit Leuven, Belgium. | lld:pubmed |
| pubmed-article:10063812 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10063812 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10063812 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10063812 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10063812 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10063812 | lld:pubmed |
